Eur. J. Nucl. Med. Mol. Imaging 2020 Jan 30
Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective study.
Schmidt-Hegemann NS, Kroeze SGC, Henkenberens C, Vogel MME, Kirste S, Becker J, Burger IA, Derlin T, Bartenstein P, Eiber M, Mix M, la Fougère C, Müller AC, Grosu AL, Combs SE, Christiansen H, Guckenberger M, Belka C
Approximately 40-70% of biochemically persistent or recurrent prostate cancer (PCa) patients after radical prostatectomy (RPE) are oligo-metastatic in ...
Read More
Source: PubMed
Med Phys 2020 Jan 25
Comparison of Statistical Machine Learning Models for Rectal Protocol Compliance in Prostate External Beam Radiation Therapy.
Jones S, Hargrave C, Deegan T, Holt T, Mengersen K
Limiting the dose to the rectum can be one of the most challenging aspects of creating a dosimetric external beam radiation therapy (EBRT) plan for pr ...
Read More
Source: PubMed
Radiother Oncol
Variation in radiotherapy patterns of care in the radical treatment of South Australian men with non-metastatic prostate cancer between 2005-2015.
Morias S, Buckley E, Beckmann K, O'Callaghan M, Borg M, Short M
To investigate associations between socio-demographic characteristics and radiotherapy patterns of care in non-metastatic prostate cancer [nmPCa] in S ...
Read More
Source: PubMed
Clin Nucl Med
99mTc-HDP Bone Scintigraphy, SPECT/CT, and 18F-FDG PET/CT Diagnosis Imaging of Incidental Pleural Mesothelioma in a Patient With Biochemical Recurrences of Prostate Cancer: Is it Really a Coincidence?
Fernández-Rodríguez P, Martín-Marcuartu JJ, Acevedo Báñez I, Masero Carretero JM, Jiménez-Hoyuela García JM
We present the case of a 69-year-old man with history of prostate carcinoma treated with prostatectomy and subsequently with external beam radiotherap ...
Read More
Source: PubMed
Brachytherapy 2020 Jan 17
Prolonged hormonal therapy and external beam radiation independently increase the risk of Persistent Hypogonadism in men treated with prostate brachytherapy.
Attalla K, Sagalovich D, Marqueen KE, Sfakianos JP, Tewari AK, Badani KK, Stock RG, Stone NN
To identify variables that predict persistent hypogonadism and castration in patients with prostate cancer (PCa) treated with brachytherapy (BT). ...
Read More
Source: PubMed
